Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.
about
Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritisIntramolecular polyspecificity in CD4 T-cell recognition of Ad-restricted epitopes of proteoglycan aggrecan.Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis.A longitudinal study on an autoimmune murine model of ankylosing spondylitis.Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health.Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases.Arthritogenic T cells drive the recovery of autoantibody-producing B cell homeostasis and the adoptive transfer of arthritis in SCID miceCitrullination only infrequently impacts peptide binding to HLA class II MHCNon-MHC risk alleles in rheumatoid arthritis and in the syntenic chromosome regions of corresponding animal models.Long-lasting tissue inflammatory processes trigger autoimmune responses to extracellular matrix molecules.Emerging drugs for axial spondyloarthritis including ankylosing spondylitis.Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens.The influence of MHC class II molecules containing the rheumatoid arthritis shared epitope on the immune response to aggrecan G1 and its peptides.Colony variability under the spotlight in animal models of arthritis.T-cell responses to versican in ankylosing spondylitis
P2860
Q27014005-83C52013-6E27-41C0-9DA7-2B7E93CD2D4EQ35171396-15E73B08-F88F-4E6D-8736-4DFE8E78CAC2Q35555515-A974F885-7999-47A5-B80B-C747C0875469Q35555732-AF018D5F-BBEA-4212-88C7-63748E95612DQ35630087-EA831D55-311D-4F81-8D7D-1F5940A521D0Q35637293-B10D9712-06FD-4FF4-A68A-52A0C93B1BC7Q36123110-ECC1B6BB-9988-4BE8-9C89-2A6DFF9FD606Q36365784-215F7580-6871-45F8-8F82-383CB0C8AF56Q36464468-F5709819-11E4-43B6-8D5C-8DED608102C9Q37147938-B30756F9-BD29-4B1F-8A48-9B3C2E9BBD73Q38068578-7ED0FCE4-F6ED-41EE-9680-4D85717437C9Q38489669-0FF104A2-0877-4D1A-8373-EC8290E1FDF5Q42617671-65DE69A1-0C09-4530-A742-E0E406B29F7DQ43120871-A7BB1501-9813-4118-96E4-E80F3AD3408EQ57673802-13E0BA19-2A79-44E6-8515-944A41A9C99D
P2860
Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Predominant cellular immune re ...... itis and rheumatoid arthritis.
@en
Predominant cellular immune re ...... itis and rheumatoid arthritis.
@nl
type
label
Predominant cellular immune re ...... itis and rheumatoid arthritis.
@en
Predominant cellular immune re ...... itis and rheumatoid arthritis.
@nl
prefLabel
Predominant cellular immune re ...... itis and rheumatoid arthritis.
@en
Predominant cellular immune re ...... itis and rheumatoid arthritis.
@nl
P2093
P356
P1433
P1476
Predominant cellular immune re ...... itis and rheumatoid arthritis.
@en
P2093
A Radbruch
M Rudwaleit
P304
P356
10.1093/RHEUMATOLOGY/KEG230
P577
2003-02-28T00:00:00Z